SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway DOI Creative Commons

Song Qi,

Lina He,

Jing Feng

et al.

Molecular and Cellular Probes, Journal Year: 2024, Volume and Issue: 78, P. 101993 - 101993

Published: Dec. 1, 2024

The prognosis of advanced osteosarcoma (OS) has remained stagnant in last decades, requiring the identification novel therapeutic targets. Recently, much attention was paid to role squalene epoxidase (SQLE), a rate-limiting enzyme cholesterol metabolism, field oncology, while specific SQLE OS not been sufficiently elucidated. present study aims investigate progression and explore potential mechanisms.

Language: Английский

Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis DOI Creative Commons
Yu Tian, Meng Zhang, Lixia Liu

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: May 10, 2024

Hepatocellular carcinoma (HCC) is a significant contributor to cancer-related deaths in the world. The development and progression of HCC are closely correlated with abnormal regulation non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long (lncRNAs), circular (circRNAs). Important biological pathways cancer biology, cell proliferation, death, metastasis, impacted by these ncRNAs, which modulate gene expression. expression raises possibility that they could be applied new biomarkers for diagnosis, prognosis, treatment targets. Furthermore, controlling genes, miRNAs can function either tumor suppressors or oncogenes. On other hand, lncRNAs play role advancement interacting molecules within cell, which, turn, affects processes chromatin remodeling, transcription, post-transcriptional processes. importance ncRNA-driven regulatory systems being highlighted current research, sheds light on behavior therapy response. This research highlights great potential ncRNAs improve patient outcomes this difficult disease landscape augmenting present methods care through use precision medicine approaches.

Language: Английский

Citations

8

Crosstalk between m6A modification and non-coding RNAs in HCC DOI

Zitong Qiu,

Xingxing Yuan, Xinyue Wang

et al.

Cellular Signalling, Journal Year: 2024, Volume and Issue: 117, P. 111076 - 111076

Published: Feb. 2, 2024

Language: Английский

Citations

6

RNA N6-Methyladenosine Modification in DNA Damage Response and Cancer Radiotherapy DOI Open Access
Cong-Zhi Wang,

Shibo Yao,

Tinghui Zhang

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(5), P. 2597 - 2597

Published: Feb. 23, 2024

The N6-methyladenosine (M6A) modification is the most common internal chemical of RNA molecules in eukaryotes. This can affect mRNA metabolism, regulate transcription, nuclear export, splicing, degradation, and translation, significantly impact various aspects physiology pathobiology. Radiotherapy method tumor treatment. Different intrinsic cellular mechanisms response cells to ionizing radiation (IR) effectiveness cancer radiotherapy. In this review, we summarize discuss recent advances understanding roles M6A methylation responses radiation-induced DNA damage determining outcomes Insights into biology may facilitate improvement therapeutic strategies for radiotherapy radioprotection normal tissues.

Language: Английский

Citations

6

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy DOI Creative Commons
Beibei Liu,

Ling Liu,

Yang Liu

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Sept. 9, 2024

Ferroptosis is a type of cell death that plays remarkable role in the growth and advancement malignancies including hepatocellular carcinoma (HCC). Non-coding RNAs (ncRNAs) have considerable impact on HCC by functioning as either oncogenes or suppressors. Recent research has demonstrated non-coding ability to control ferroptosis cells, hence impacting tumors resistance these cells drugs. Autophagy mechanism conserved throughout evolution maintaining balance body under normal settings. Nevertheless, occurrence dysregulation autophagy evident progression various human disorders, specifically cancer. dual roles cancer, potentially influencing both survival death. prevalent kind liver genetic mutations changes molecular pathways might worsen its advancement. The subject debate, it capacity repress promote tumor growth. activation can apoptosis, proliferation glucose metabolism, facilitate spread through EMT. Inhibiting hinder enhance respond treatment. regulated several signaling pathways, such STAT3, Wnt, miRNAs, lncRNAs, circRNAs. Utilizing anticancer drugs target may advantageous implications for efficacy cancer

Language: Английский

Citations

5

The epigenetic regulatory network of long noncoding RNAs in hepatocellular carcinoma DOI Creative Commons

Zhaoqi Shi,

Shengxi Jin, Xiaolong Liu

et al.

Genes & Diseases, Journal Year: 2025, Volume and Issue: unknown, P. 101534 - 101534

Published: Jan. 1, 2025

Language: Английский

Citations

0

Emerging importance of m6A modification in liver cancer and its potential therapeutic role DOI
Tao Chen,

Wufei Ye,

Songsen Gao

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2025, Volume and Issue: unknown, P. 189299 - 189299

Published: March 1, 2025

Language: Английский

Citations

0

M6A-modified BFSP1 induces aerobic glycolysis to promote liver cancer growth and metastasis through upregulating tropomodulin 4 DOI Creative Commons

Rong Li,

Shunle Li,

Lin Shen

et al.

Molecular Biomedicine, Journal Year: 2025, Volume and Issue: 6(1)

Published: March 18, 2025

Abstract RNA N6-methyladenosine (m6A) is a common modification in eukaryotes, and its abnormal regulation closely related to cancer progression. Aerobic glycolysis main way for cells obtain energy. It was found that beaded filament structural protein 1 (BFSP1) m6A gene liver cancer. However, the effect of m6A-modified BFSP1 on aerobic how it regulated progression have not been explored. Here, we upregulated tissues. Overexpression promoted viability, invasion, cells, whereas knockdown showed opposite effects. Co-immunoprecipitation, immunofluorescence GST pull down analyses directly interacted with tropomodalin 4 (TMOD4), TMOD4 reversed overexpression-induced malignant phenotypes cells. Moreover, methyltransferase-like 3 (METTL3) enhanced stability by augmenting mRNA, which achieved YTHDF1-dependent manner. In vivo experiments mice confirmed METTL3 increased promoting inhibited tumor growth metastasis. summary, METTL3-mediated methylation mRNA plays an important role cancer, providing potential therapeutic strategy

Language: Английский

Citations

0

KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression DOI Creative Commons
Wei Guo, Tan Wang,

Qilin Huai

et al.

Thoracic Cancer, Journal Year: 2024, Volume and Issue: 15(18), P. 1397 - 1409

Published: May 8, 2024

Abstract Background Alterations in epigenetic factors are recognized as key contributors to the emergence of human cancer. The active and reversible alteration N6‐methyladenosine (m6A) RNA is crucial for controlling gene activity determining cellular destiny. Even with these insights, triggering KIAA1429 (also called VIRMA) its role lung adenocarcinoma (LUAD) mostly unclear. As a result, objective this study was elucidate how contributes cancer development LUAD. Methods This utilized multiple methods investigation, encompassing vitro functional examination cells, transcriptome sequencing, methylation immunoprecipitation sequencing (MeRIP‐seq), well stability tests ascertain half‐life target genes. Results results indicated that modifying expression regulated proliferation metastasis By employing alongside MeRIP‐seq analysis, research pinpointed genes affected by m6A alterations triggered KIAA1429. In more detailed manner, it discovered plays regulatory ARHGAP30. Suppressing reduced levels mRNA ARHGAP30, boosting expression, thus inhibiting tumor metastasis. Conclusion revealed activation mechanism pivotal function LUAD development, paving way molecular‐based interventions

Language: Английский

Citations

3

Oncogenic mechanisms of COL10A1 in cancer and clinical challenges (Review) DOI Creative Commons

Qiang Yi,

Gangfeng Zhu,

Weijian Zhu

et al.

Oncology Reports, Journal Year: 2024, Volume and Issue: 52(6)

Published: Oct. 8, 2024

Collagen type X α1 chain (COL10A1), a gene encoding the α‑1 of collagen, serves key role in conferring tensile strength and structural integrity to tissues. Upregulation COL10A1 expression has been observed different malignancies, including lung, gastric pancreatic cancer, is associated with poor prognosis. The present review provides an updated synthesis evolving biological understanding COL10A1, particular focus on its mechanisms action regulatory functions within context tumorigenesis. For example, it established that increased promotes cancer progression by activating multiple signaling pathways, TGF‑β1/Smad, MEK/ERK focal adhesion kinase thereby inducing proliferation, invasion migration. Additionally, demonstrated induce epithelial‑mesenchymal transition reshapes extracellular matrix tumor Furthermore, basis methyltransferase‑like 3‑mediated N6‑methyladenosine methylation, intricately regulates epitranscriptomic machinery, augmenting oncogenic role. However, although pivotal transcription orchestration growth, question whether would serve as viable therapeutic target remains subject scientific hypothesis requiring rigorous examination. Variables such distinct microenvironments treatment associations necessitate further experimental validation. Therefore, comprehensive assessment functional mechanistic roles may pave way for development innovative strategies.

Language: Английский

Citations

3

RNA N6-Methyladenosine Modification in DNA Damage Response and Cancer Radiotherapy DOI Open Access
Cui Wang,

Shibo Yao,

Tinghui Zhang

et al.

Published: Jan. 12, 2024

N6-methyladenosine (M6A) modification is the most abundant internal chemical on RNA molecules in eukaryotes and can affect mRNA metabolism regulate transcription, nuclear export, splicing, degradation, translation, ets, has a significant impact various aspects of physiology or pathobiology. Radiotherapy common measure tumor treatment, variety cellular intrinsic mechanisms responses cells to ionizing radiation (IR) effectiveness cancer radiotherapy. In this review, we summarize discuss recent advances about roles M6A methylation radiation-induced DNA damage response, outcomes Insights into biology may facilitate improvement therapeutic strategies for radiotherapy as well radioprotection normal tissues.

Language: Английский

Citations

2